ASHT - Stewart,B.; Ironside,J.W.; Fraser,J.R. - Quantification or scrapie pathology following infection by the intramuscular, intraperitoneal and oral routes - Brain Pathology 1997; 7(4): 1380
ACXD - Cousens,S.N.; Smith,P.G.; Ward,H.J.T.; Everington,D.; Knight,R.S.G.; Zeidler,M.; Stewart,G.; Smith-Bathgate,E.A.; Macleod,M.A.; Mackenzie,J.; Will,R.G. - Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000 - Lancet 2001 Mar 31; 357(9261): 1002-7
ACXE - Cousens,S.N.; Linsell,L.; Smith,P.G.; Chandrakumar,M.; Wilesmith,J.W.; Knight,R.S.G.; Zeidler,M.; Stewart,G.; Will,R.G. - Geographical distribution of variant CJD in the UK (excluding Northern Ireland) - Lancet 1999 Jan 2; 353(9146): 18-21
AGPO - Knight,R.S.G.; Stewart,G. - The new variant form of Creutzfeldt-Jakob disease - FEMS Immunology and Medical Microbiology 1998 Jun; 21(2): 97-100
ARLR - Linsell,L.; Cousens,S.N.; Smith,P.G.; Knight,R.S.G.; Zeidler,M.; Stewart,G.; de Silva,R.; Esmonde,T.F.G.; Ward,H.J.T.; Will,R.G. - A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering. - Neurology 2004 Dec 14; 63(11): 2077-83
AMOD - Will,R.G.; Knight,R.S.G.; Zeidler,M.; Stewart,G.; Ironside,J.W.; Cousens,S.N.; Smith,P.G. - Reporting of suspect new variant Creutzfeldt-Jakob disease - Lancet 1997 Mar 22; 349(9055): 847
AMYM - Zeidler,M.; Sellar,R.J.; Collie,D.A.; Knight,R.S.G.; Stewart,G.; Macleod,M.A.; Ironside,J.W.; Cousens,S.N.; Colchester,A.F.C.; Hadley,D.M.; Will,R.G. - The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease - Lancet 2000 Apr 22; 355(9213): 1412-8
AMYO - Zeidler,M.; Knight,R.S.G.; Stewart,G.; Ironside,J.W.; Will,R.G.; Green,A.J.E.; Pocchiari,M. - Diagnosis of Creutzfeldt-Jakob disease. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified. - British Medical Journal 1999 Feb 20; 318(7182): 538
AMYS - Zeidler,M.; Stewart,G.; Cousens,S.N.; Estibeiro,K.; Will,R.G. - Codon 129 genotype and new variant CJD - Lancet 1997 Aug 30; 350(9078): 668
AAZE - Barclay,G.R.; Munks,R.; Stewart,G.E.; Turner,M.L.; Will,R.G. - Variant Creutzfeldt-Jakob disease is not related to underlying IgA deficiency - Transfusion Medicine 1999 Dec; 9(4): 383-4
AEVV - Green,A.J.E.; Thompson,E.J.; Stewart,G.E.; Zeidler,M.; McKenzie,J.M.; Macleod,M.A.; Ironside,J.W.; Will,R.G.; Knight,R.S.G. - Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease - Journal of Neurology, Neurosurgery and Psychiatry 2001 Jun; 70(6): 744-8
AHRP - Macleod,M.A.; Stewart,G.E.; Zeidler,M.; Will,R.; Knight,R.S.G. - Sensory features of variant Creutzfeldt-Jakob disease - Journal of Neurology. Zeitschrift für Neurologie 2002 Jun; 249(6): 706-11
ALED - Stewart,G.E.; Ironside,J.W. - New variant Creutzfeldt-Jakob disease - Current Opinion in Neurology 1998 Jun; 11(3): 259-62
AMNU - Will,R.G.; Zeidler,M.; Stewart,G.E.; Macleod,M.A.; Ironside,J.W.; Cousens,S.N.; Mackenzie,J.; Estibeiro,K.; Green,A.J.E.; Knight,R.S.G. - Diagnosis of new variant Creutzfeldt-Jakob disease - Annals of Neurology 2000 May; 47(5): 575-82
AMYR - Zeidler,M.; Stewart,G.E.; Barraclough,C.R.; Bateman,D.E.; Bates,D.; Burn,D.J.; Colchester,A.F.C.; Durward,W.; Fletcher,N.A.; Hawkins,S.A.C.; Mackenzie,J.M.; Will,R.G. - New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. - Lancet 1997 Sep 27; 350(9082): 903-7
ALEE - Stewart,G.T. - vCJD: the epidemic that never was. Author has overlooked several findings that support his argument. - British Medical Journal 2002 Jul 13; 325(7355): 103
ALEF - Stewart,G.T. - More on BSE/vCJD - Journal of the Royal Society of Medicine 2002 Feb; 95(2): 112
AYHL - Lawson,V.A.; Stewart,J.D.; Masters,C.L. - Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain - Journal of General Virology 2007 Oct; 88(10): 2905-14
ATIX - Lawson,V.A.; Stewart,J.D.; Masters,C.L. - Development of an enzymatic detergent treatment protocol that significantly reduces protease resistant prion protein load and infectivity from prion contaminated surgical steel monofilaments. - International Conference - Prion 2005: Between fundamentals and society's needs - 19.10.-21.10.2005, Congress Center Düsseldorf - Poster Session: Decontamination DEC-04
ALEG - Stewart,J.S.S.; Jeffrey,B. - Beef safety and publication of scientific information - Lancet 1996 Jun 8; 347(9015): 1635
ABTP - Brown,K.L.; Stewart,K.; Ritchie,D.; Fraser,H.; Morrison,W.I.; Bruce,M.E. - Follicular dendritic cells in scrapie pathogenesis - Archives of Virology. Supplementum 2000(16): 13-21
ABTQ - Brown,K.L.; Stewart,K.; Ritchie,D.L.; Mabbott,N.A.; Williams,A.; Fraser,H.; Morrison,W.I.; Bruce,M.E. - Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells - Nature Medicine 1999 Nov; 5(11): 1308-12
ABTR - Brown,K.L.; Stewart,K.; Bruce,M.E.; Fraser,H. - Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy - Journal of General Virology 1997 Oct; 78(10): 2707-10
ABTS - Brown,K.L.; Stewart,K.; Bruce,M.E.; Fraser,H. - Scrapie in immunodeficient mice - Biochemical Society Transactions 1997 May; 25(2): 173S
AEEG - Fraser,H.; Brown,K.L.; Stewart,K.; McConnell,I.; McBride,P.A.; Williams,A. - Replication of scrapie in spleens of SCID mice follows reconstitution with wild-type mouse bone marrow - Journal of General Virology 1996 Aug; 77(8): 1935-40
ACEY - Cappai,R.; Stewart,L.; Jobling,M.F.; Thyer,J.M.; White,A.R.; Beyreuther,K.; Collins,S.J.; Masters,C.L.; Barrow,C.J. - Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation. - Biochemistry 1999 Mar 16; 38(11): 3280-4
AWGK - Harris,D.A.; Stewart,L.; Christensen,H.M.; Roth,K.A.; Chiesa,R.; Li,A. - Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125 - International Conference - Prion 2006: Strategies, advances and trends towards protection of society - 3.10.-6.10.2006, Torino, Italy, Lingotto Conference Centre - Oral sessions ORAL-28
AXQA - Knight,R.; Stewart,L.; Rydzewska,L.; Keogh,G.; Chalmers,I.; Firkins,L.; Walker,S. - A Systematic Review of Therapeutic Interventions for Human Prion Disease - International Conference - Prion 2007 (26.-28.9.2007) Edinburgh International Conference Centre, Edinburgh, Scotland, UK - Book of Abstracts: Oral Abstracts FC5.4
ANQB - Drisaldi,B.; Stewart,R.S.; Adles,C.; Stewart,L.R.; Quaglio,E.; Biasini,E.; Fioriti,L.; Chiesa,R.; Harris,D.A. - Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation - The Journal of Biological Chemistry 2003 Jun 13; 278(24): 21732-43
ARPG - Fioriti,L.; Dossena,S.; Stewart,L.R.; Stewart,R.S.; Harris,D.A.; Forloni,G.; Chiesa,R. - Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations - The Journal of Biological Chemistry 2005 Mar 25; 280(12): 11320-8
AGAY - Jobling,M.F.; Huang,X.; Stewart,L.R.; Barnham,K.J.; Curtain,C.C.; Volitakis,I.; Perugini,M.; White,A.R.; Cherny,R.A.; Masters,C.L.; Barrow,C.J.; Collins,S.J.; Bush,A.I.; Cappai,R. - Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126 - Biochemistry 2001 Jul 10; 40(27): 8073-84
AGAZ - Jobling,M.F.; Stewart,L.R.; White,A.R.; McLean,C.; Friedhuber,A.; Maher,F.; Beyreuther,K.; Masters,C.L.; Barrow,C.J.; Collins,S.J.; Cappai,R. - The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126 - Journal of Neurochemistry 1999 Oct; 73(4): 1557-65
AVZV - Li,A.; Christensen,H.M.; Stewart,L.R.; Roth,K.A.; Chiesa,R.; Harris,D.A. - Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125 - EMBO Journal 2007 Jan 24; 26(2): 548-58
ALEH - Stewart,L.R.; White,A.R.; Jobling,M.F.; Needham,B.E.; Maher,F.; Thyer,J.; Beyreuther,K.; Masters,C.L.; Collins,S.J.; Cappai,R. - Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126 - Journal of Neuroscience Research 2001 Sep 15; 65(6): 565-72
ANSX - White,A.R.; Maher,F.; Brazier,M.W.; Jobling,M.F.; Thyer,J.; Stewart,L.R.; Thompson,A.; Gibson,R.; Masters,C.L.; Multhaup,G.; Beyreuther,K.; Barrow,C.J.; Collins,S.J.; Cappai,R. - Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation - Brain Research 2003 Mar 21; 966(2): 231-44
AMKP - White,A.R.; Collins,S.J.; Maher,F.; Jobling,M.F.; Stewart,L.R.; Thyer,J.M.; Beyreuther,K.; Masters,C.L.; Cappai,R. - Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity - American Journal of Pathology 1999 Nov; 155(5): 1723-30
AVOT - Goldmann,W.; Houston,E.F.; Stewart,P.; Perucchini,M.; Foster,J.; Hunter,N. - Ovine prion protein variant A(136)R(154)L(168)Q(171) increases resistance to experimental challenge with bovine spongiform encephalopathy agent - Journal of General Virology 2006 Dec; 87(12): 3741-5
ATML - Goldmann,W.; Baylis,M.; Foster,J.; Stevenson,E.; Stewart,P.; Hunter,N. - Frequencies of PrP gene haplotypes in British sheep flocks - International Conference - Prion 2005: Between fundamentals and society's needs - 19.10.-21.10.2005, Congress Center Düsseldorf - Poster Session: Genetics, strains and emerging problems GEN-11
AXXF - Stewart,P.; Perucchini,M.; Goldmann,W. - Speculations on PrP Protein Sequence Variation and Transmission Barriers - International Conference - Prion 2007 (26.-28.9.2007) Edinburgh International Conference Centre, Edinburgh, Scotland, UK - Book of Abstracts: Epidemiology, Risk Assessment and Transmission P04.111
ANQB - Drisaldi,B.; Stewart,R.S.; Adles,C.; Stewart,L.R.; Quaglio,E.; Biasini,E.; Fioriti,L.; Chiesa,R.; Harris,D.A. - Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation - The Journal of Biological Chemistry 2003 Jun 13; 278(24): 21732-43
ARPG - Fioriti,L.; Dossena,S.; Stewart,L.R.; Stewart,R.S.; Harris,D.A.; Forloni,G.; Chiesa,R. - Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations - The Journal of Biological Chemistry 2005 Mar 25; 280(12): 11320-8
ASJO - Fioriti,L.; Quaglio,E.; Massignan,T.; Colombo,L.; Stewart,R.S.; Salmona,M.; Harris,D.A.; Forloni,G.; Chiesa,R. - The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species - Molecular and Cellular Neurosciences 2005 Jan; 28(1): 165-76
ASRM - Stewart,R.S.; Harris,D.A. - A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons - The Journal of Biological Chemistry 2005 Apr 22; 280(16): 15855-64
AUDY - Stewart,R.S.; Piccardo,P.; Ghetti,B.; Harris,D.A. - Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein - Journal of Neuroscience 2005 Mar 30; 25(13): 3469-77
APMG - Stewart,R.S.; Harris,D.A. - Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection - The Journal of Biological Chemistry 2003 Nov 14; 278(46): 45960-8
ALEI - Stewart,R.S.; Drisaldi,B.; Harris,D.A. - A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum - Molecular Biology of the Cell 2001 Apr; 12(4): 881-9
ALEJ - Stewart,R.S.; Harris,D.A. - Most pathogenic mutations do not alter the membrane topology of the prion protein - The Journal of Biological Chemistry 2001 Jan 19; 276(3): 2212-20
ATUV - Stewart,W.C.; Pollock,K.G.; Browning,L.M.; Young,D.; Smith-Palmer,A.; Reilly,W.J. - Survey of zoonoses recorded in Scotland between 1993 and 2002 - The Veterinary Record 2005 Nov 26; 157(22): 697-702